BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22837720)

  • 1. Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer.
    Li X; Wang J; Xu Z; Ahmad A; Li E; Wang Y; Qin S; Wang Q
    Int J Mol Sci; 2012; 13(6):7663-7675. PubMed ID: 22837720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells.
    Wan X; Ma D; Song G; Tang L; Jiang X; Tian Y; Yi Z; Jiang C; Jin Y; Hu A; Bai Y
    J Bioenerg Biomembr; 2024 Jun; 56(3):323-332. PubMed ID: 38441855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Overexpression of Oct4 in Advanced Stage Gallbladder Carcinoma.
    Singh D; Biswas D; Tewari M; Kar AG; Ansari MA; Singh S; Narayan G
    J Gastrointest Cancer; 2023 Dec; 54(4):1231-1239. PubMed ID: 36705780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC).
    Rodriguez E; Chen L; Ao MH; Geddes S; Gabrielson E; Askin F; Zhang H; Li QK
    Transl Respir Med; 2014 Dec; 2(1):10. PubMed ID: 25346886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the influencing factors of false negative autoantibodies in patients with non-small cell lung cancer.
    Wang A; Hao Y; Huo Y; Xu X; Zhang Y
    Front Oncol; 2024; 14():1358387. PubMed ID: 38800369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2
    Yang F; Zhang J; Yang H
    Onco Targets Ther; 2018; 11():7873-7881. PubMed ID: 30464534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of stem cell transcription factors Nanog and Oct4 in renal cell carcinoma tissues and clinical significance.
    Yu B; Cai H; Xu Z; Xu T; Zou Q; Gu M
    Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1818-1823. PubMed ID: 26631537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of stem cells in lung cancer.
    Romeo HE; Barreiro Arcos ML
    World J Stem Cells; 2023 Jun; 15(6):576-588. PubMed ID: 37424954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression.
    Di Bonaventura R; Martini M; Cenci T; Caccavella VM; Barresi V; Gessi M; Albanese A; Lauretti L; Pallini R; D'Alessandris QG; Olivi A
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines.
    Canals J; Navarro A; Vila C; Canals JM; Díaz T; Acosta-Plasencia M; Cros-Font C; Han B; He Y; Monzó M
    J Exp Clin Cancer Res; 2022 Jan; 41(1):37. PubMed ID: 35081981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Iron Chelators on the Biology of Cancer Stem Cells.
    Szymonik J; Wala K; Górnicki T; Saczko J; Pencakowski B; Kulbacka J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotency Stemness and Cancer: More Questions than Answers.
    Hatina J; Kripnerová M; Houdek Z; Pešta M; Tichánek F
    Adv Exp Med Biol; 2022; 1376():77-100. PubMed ID: 34725790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma.
    Paterson C; Kilmister EJ; Brasch HD; Bockett N; Patel J; Paterson E; Purdie G; Galvin S; Davis PF; Itinteang T; Tan ST
    Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depleting SOX2 improves ischemic stroke via lncRNA PVT1/microRNA-24-3p/STAT3 axis.
    Chen Z; Fan T; Zhao X; Zhang Z
    Mol Med; 2021 Sep; 27(1):107. PubMed ID: 34521353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.
    Hosseini-Khah Z; Babaei MR; Tehrani M; Cucchiarini M; Madry H; Ajami A; Rakhshani N; Rafiei A; Nikbin B
    Curr Oncol; 2021 Aug; 28(4):3015-3029. PubMed ID: 34436030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis prognostic factors and cancer stem cell-related transcription factors associated with metastasis induction in canine metastatic mammary gland tumors.
    Kim S; Bok E; Lee S; Lee HJ; Choe Y; Kim NH; Lee WJ; Rho GJ; Lee SL
    J Vet Sci; 2021 Sep; 22(5):e62. PubMed ID: 34423600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
    He D; Zhang X; Tu J
    Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas.
    Pedregal-Mallo D; Hermida-Prado F; Granda-Díaz R; Montoro-Jiménez I; Allonca E; Pozo-Agundo E; Álvarez-Fernández M; Álvarez-Marcos C; García-Pedrero JM; Rodrigo JP
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.
    Wuputra K; Ku CC; Wu DC; Lin YC; Saito S; Yokoyama KK
    J Exp Clin Cancer Res; 2020 Jun; 39(1):100. PubMed ID: 32493501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of iPS87, a prostate cancer stem cell-like cell line.
    Assoun EN; Meyer AN; Jiang MY; Baird SM; Haas M; Donoghue DJ
    Oncotarget; 2020 Mar; 11(12):1075-1084. PubMed ID: 32256979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.